Matches in Ghent University Academic Bibliography for { <https://biblio.ugent.be/publication/01JN3EMCTGT0WDASPY2G07B7KP> ?p ?o. }
Showing items 1 to 22 of
22
with 100 items per page.
- 01JN3EMCTGT0WDASPY2G07B7KP classification U.
- 01JN3EMCTGT0WDASPY2G07B7KP date "2025".
- 01JN3EMCTGT0WDASPY2G07B7KP language "und".
- 01JN3EMCTGT0WDASPY2G07B7KP type journalArticle.
- 01JN3EMCTGT0WDASPY2G07B7KP hasPart 01JN3JKRY36H2EHBGXJPMD7J73.pdf.
- 01JN3EMCTGT0WDASPY2G07B7KP doi "10.1177/20552076251319169".
- 01JN3EMCTGT0WDASPY2G07B7KP volume "11".
- 01JN3EMCTGT0WDASPY2G07B7KP abstract "Objective. To evaluate the cost-effectiveness of a digital supportive healthcare pathway in patients with type 2 diabetes mellitus (T2DM) compared to usual care. Methods. An age-dependent Markov model was applied from a healthcare payer perspective projecting results of a clinical trial study over a time horizon of 22 years assuming a continuous implementation of the intervention every year, 24/7. The setting was Flanders (Belgium). One-way and probabilistic sensitivity analyses were performed. Results. The hybrid care pathway led to a quality-adjusted life year (QALY) gain of 5.97, while the costs increased with €663,036. This resulted in an incremental cost-effectiveness ratio of €110,989/QALY. With a cost-effectiveness threshold of 45,000€/QALY, the hybrid care pathway was found not cost-effective compared to the usual care trajectory. Sensitivity analyses showed that over 50\% of iterations exceeded the threshold, with a cost-effectiveness probability of 13.12% at €45,000/QALY. Conclusions. This cost-effectiveness analysis indicates that a hybrid care pathway is unlikely to be a cost-effective approach compared to the standard care trajectory in patients with T2DM. Nevertheless, the exploration of technology-driven healthcare pathways are vital for advancing patient well-being, emphasizing the need for further research to optimize resource utilization and enhance outcomes effectively.".
- 01JN3EMCTGT0WDASPY2G07B7KP author 1D3A71B0-386D-11E4-882E-3A0DB5D1D7B1.
- 01JN3EMCTGT0WDASPY2G07B7KP author 2011FDFE-F0EE-11E1-A9DE-61C894A0A6B4.
- 01JN3EMCTGT0WDASPY2G07B7KP author FAB57086-F0ED-11E1-A9DE-61C894A0A6B4.
- 01JN3EMCTGT0WDASPY2G07B7KP author FBE18AF8-F0ED-11E1-A9DE-61C894A0A6B4.
- 01JN3EMCTGT0WDASPY2G07B7KP author urn:uuid:464c6780-5ff8-4b27-a5ea-b2d17dbd8d45.
- 01JN3EMCTGT0WDASPY2G07B7KP author urn:uuid:5a933b77-e91b-4dcb-a321-75b858a1f574.
- 01JN3EMCTGT0WDASPY2G07B7KP author urn:uuid:eec8e5a2-3877-4175-ac99-8c6473d15827.
- 01JN3EMCTGT0WDASPY2G07B7KP dateCreated "2025-02-27T10:18:28Z".
- 01JN3EMCTGT0WDASPY2G07B7KP dateModified "2025-02-27T11:28:05Z".
- 01JN3EMCTGT0WDASPY2G07B7KP name "Cost-effectiveness of a digital supportive healthcare pathway for type 2 diabetes compared to usual care in Belgium".
- 01JN3EMCTGT0WDASPY2G07B7KP pagination urn:uuid:f47c183e-8e05-4e22-85d5-3647489765ea.
- 01JN3EMCTGT0WDASPY2G07B7KP sameAs LU-01JN3EMCTGT0WDASPY2G07B7KP.
- 01JN3EMCTGT0WDASPY2G07B7KP sourceOrganization urn:uuid:49678974-5616-42e6-9126-5281e5573f71.
- 01JN3EMCTGT0WDASPY2G07B7KP type U.